Form 4: ADMA Biologics CFO Brad L. Tade Reports Acquisition of Restricted Stock Units and Stock Options

CFO and Treasurer of ADMA Biologics, Brad L. Tade, reports the acquisition of restricted stock units and stock options, increasing his beneficial ownership in the company.

Summary

• On February 19, 2025, Brad L. Tade, CFO and Treasurer of ADMA Biologics, acquired 62,227 restricted stock units (RSUs) and 93,023 stock options.
• The RSUs vest quarterly over four years from the grant date, contingent upon continued service.
• The stock options vest over four years, with 25% vesting on the first anniversary and the remaining 75% vesting monthly over the subsequent three years.
• Following these transactions, Tade's total beneficial ownership includes 261,660 shares of common stock and 93,023 stock options.
• The reported transactions were filed with the SEC on February 21, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of equity by a key executive suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of RSUs and stock options by a key executive like the CFO can be seen as a positive sign, indicating confidence in the company's future performance.
• The vesting schedules for both RSUs and stock options incentivize long-term commitment from the CFO.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules suggest an expectation of continued service and company performance over the next four years.

Industry Context

This type of SEC filing is standard for reporting changes in beneficial ownership by company insiders. It provides transparency to investors regarding the equity holdings of key executives.

Stakeholder Impact

• Shareholders may view the increased equity stake of the CFO as a positive signal.
• Employees may see this as a sign of stability and confidence in the company's leadership.

Key Dates

Keywords

ADMA Biologics, Brad L. Tade, CFO, restricted stock units, stock options, beneficial ownership, Form 4, SEC filing, equity compensation